Abstract: Provided is an integrated circuit including at least one cell, the at least one cell includes first and second active regions spaced apart from each other, a dummy region disposed between the first and second active regions, at least one first active fin disposed in the first active region and extending in a first direction, at least one second active fin extending along the first direction over the entire length of the second active region, and an active gate line extending in a second direction that is substantially perpendicular to the first direction, wherein the active gate line vertically overlaps the first active region and the dummy region and does not vertically overlap the second active region.

Abstract: A composition for manufacturing a polyurethane foam with a low content of volatile organic compounds such as acetaldehyde, and a method of manufacturing a polyurethane foam using the same are disclosed. The composition for manufacturing the polyurethane foam includes a polyol composition having a polypropylene glycol content of 0.1 ppm or less and a propylene oxide content of 16 ppm or less, isocyanate, and a volatile organic compound (VOC) reducing agent. The method for manufacturing the polyurethane foam includes adding raw materials to a reactor to polymerize a polyol composition, removing impurities from the reactor; and obtaining the polyurethane foam from reactants from which the impurities are removed.

Abstract: The present invention discloses a blockchain information determination server and a recording medium in which a program is recorded. In other words, the present invention is intended to overcome the above-described problems, and provides a technology that performs the confirmative determination of report information regarding fake news by calculating the degrees of reliability of actors who participate in a blockchain. According to the present invention, the following effects are achieved: First, the report information used to determine whether news is fake news may be shared by multiple subjects. Second, the present invention contributes to the activation of a system by providing rewards to a subject who determines whether news is fake news and a system management subject via reliability. Third, the present invention contributes to the automation of the blocking of fake news by performing the probabilistic determination of whether news is fake news based on reliability.

Abstract: Disclosed a precursor compound for producing a photoactive layer of a thin film solar cell that may be used as a precursor of a CIS, CGS or CIGS thin film that may be used as a photoactive layer of a solar cell, and a production method thereof. The precursor compound is represented by a following Chemical Formula 1: wherein, in the Chemical Formula 1, X represents indium (In) or gallium (Ga), Y represents chlorine (Cl) or iodine (I), each of R1, R2, R3 and R4 independently represents a methyl group, a propyl group or an alkyl group having 2 to 10 carbon atoms.

Abstract: Compositions and methods are provided for lamellar and defect reconstruction of corneal stromal tissue using biomaterials that form a defined gel structure in situ. Such gels can serve as cellular or acellular lamellar substitutes to reconstruct corneal stroma, facilitate matrix remodeling, and support multilayered re-epithelialization of wounded corneal stromal tissue, as well delivery vehicles for cells, biomolecules, and/or pharmaceutical agents to wound sites throughout the body.

Abstract: The present invention relates to a polypeptide improved in protein purity and in affinity for a target antigen, a conjugate thereof with an antibody or antigen-binding fragment, and a preparation method of the polypeptide and the conjugate. The polypeptide or the conjugate thereof according to the present invention does not undergo glycosylation even when produced in a eukaryotic cell and thus has high protein purity and affinity for a target antigen, showing a very high value as a reagent for diagnosis or treatment of a disease.

Abstract: A battery module that effectively protects internal components from external impact and increases manufacturing efficiency is disclosed. The battery module includes a plurality of can type secondary batteries arranged to be laid down in a horizontal direction; a bus bar at least partially formed of an electrically conductive material to electrically connect the plurality of can type secondary batteries; and a module case in which an inner space is formed to accommodate the plurality of can type secondary batteries, and comprising an outer wall formed to surround the inner space and a bumper portion configured to protrude from an outer surface of the outer wall in an outer direction to absorb an external impact.

Abstract: A battery pack that protects an internal configuration from external impact and effectively prevents internal short circuit is disclosed. The battery pack includes a plurality of can type secondary batteries arranged to be laid down in a horizontal direction; a bus bar at least partially formed of an electrically conductive material to electrically connect the plurality of can type secondary batteries; at least one module case with an empty space formed inside to accommodate the plurality of can type secondary batteries; and an insulating tube configured to surround an outer wall of the module case and having an outer surface on which a plurality of embossing structures with a part bulging in an outer direction are formed.

Abstract: Provided is an integrated circuit including at least one cell, the at least one cell includes first and second active regions spaced apart from each other, a dummy region disposed between the first and second active regions, at least one first active fin disposed in the first active region and extending in a first direction, at least one second active fin extending along the first direction over the entire length of the second active region, and an active gate line extending in a second direction that is substantially perpendicular to the first direction, wherein the active gate line vertically overlaps the first active region and the dummy region and does not vertically overlap the second active region.

Abstract: Provided is an integrated circuit including at least one cell, the at least one cell includes first and second active regions spaced apart from each other, a dummy region disposed between the first and second active regions, at least one first active fin disposed in the first active region and extending in a first direction, at least one second active fin extending along the first direction over the entire length of the second active region, and an active gate line extending in a second direction that is substantially perpendicular to the first direction, wherein the active gate line vertically overlaps the first active region and the dummy region and does not vertically overlap the second active region.

Abstract: Disclosed a precursor compound for producing a photoactive layer of a thin film solar cell that may be used as a precursor of a CIS, CGS or CIGS thin film that may be used as a photoactive layer of a solar cell, and a production method thereof. The precursor compound is represented by a following Chemical Formula 1: wherein, in the Chemical Formula 1, X represents indium (In) or gallium (Ga), Y represents chlorine (Cl) or iodine (I), each of R1, R2, R3 and R4 independently represents a methyl group, a propyl group or an alkyl group having 2 to 10 carbon atoms.

Abstract: Provided is an integrated circuit including at least one cell, the at least one cell includes first and second active regions spaced apart from each other, a dummy region disposed between the first and second active regions, at least one first active fin disposed in the first active region and extending in a first direction, at least one second active fin extending along the first direction over the entire length of the second active region, and an active gate line extending in a second direction that is substantially perpendicular to the first direction, wherein the active gate line vertically overlaps the first active region and the dummy region and does not vertically overlap the second active region.

Abstract: Provided is a cosmetic composition for improving skin conditions including a fusion protein containing a skin penetration enhancing peptide, more particularly, a fusion protein in which PDGFa is bound to the skin penetration enhancing peptide, and a cosmetic composition for improving skin conditions, a functional cosmetic product for improving skin conditions, a cosmetic composition for preventing and treating alopecia, and a quasi-drug composition each including the fusion protein.

Abstract: A battery cell has a structure in which outer peripheral portions of a battery case are sealed by thermal bonding in a state in which an electrode assembly is mounted together with an electrolyte in a battery case made of a laminate sheet, wherein a pair of electrode leads of the electrode assembly protrude outward from the battery case, and an insulating member is attached to each of the electrode leads in an area of at least 60% of a total area of the electrode leads that protrude outwardly.

Abstract: The present invention relates to a skin administration system capable of improving the efficiency of skin delivery of an ingredient for controlling release of neurotransmitters and, particularly, to a microneedle containing an ingredient for controlling release of neurotransmitters.

Abstract: A novel antibody against VEGFR2 for use in the prevention or treatment of macular degeneration and cancer, which are angiogenesis-related diseases. The antibody of the present invention is an antibody which specifically binds to VEGFR2 which is overexpressed in vascular endothelial cells. The antibody of the present invention has very low homology compared to the CDR sequences of conventional VEGFR2 target antibodies, and thus is unique in its sequence. Since the antibody of the present invention, when treated alone, has the ability to inhibit vascular endothelial cell growth equivalent to that of ramucirumab which is conventionally used, it is very effective to prevent or treat angiogenesis-related diseases.

Abstract: The present invention relates to a skin administration system capable of improving the efficiency of skin delivery of an ingredient for controlling release of neurotransmitters and, particularly, to a microneedle containing an ingredient for controlling release of neurotransmitters.

Abstract: Provided is an integrated circuit including at least one cell, the at least one cell includes first and second active regions spaced apart from each other, a dummy region disposed between the first and second active regions, at least one first active fin disposed in the first active region and extending in a first direction, at least one second active fin extending along the first direction over the entire length of the second active region, and an active gate line extending in a second direction that is substantially perpendicular to the first direction, wherein the active gate line vertically overlaps the first active region and the dummy region and does not vertically overlap the second active region.

Abstract: A method of manufacturing a slim foam pad for vehicle seats, may include injecting a first foam solution into a first mold to manufacture an upper pad; inserting the manufactured upper pad into a second mold; and injecting a second foam solution to a first surface of the upper pad inserted into the second mold to manufacture a lower pad integrally coupled to the upper pad, wherein the second foam solution is foamed in a state of being in direct contact with the first surface of the upper pad, wherein no additional border separation member is provided at a border between the upper pad and the lower pad.

Abstract: A novel antibody against VEGFR2 for use in the prevention or treatment of macular degeneration and cancer, which are angiogenesis-related diseases. The antibody of the present invention is an antibody which specifically binds to VEGFR2 which is overexpressed in vascular endothelial cells. The antibody of the present invention has very low homology compared to the CDR sequences of conventional VEGFR2 target antibodies, and thus is unique in its sequence. Since the antibody of the present invention, when treated alone, has the ability to inhibit vascular endothelial cell growth equivalent to that of ramucirumab which is conventionally used, it is very effective to prevent or treat angiogenesis-related diseases.